Study guide

4.5 Vital Signs, Normal Laboratory Values & Intra-Procedural Lab Monitoring

Registered Cardiac Electrophysiology Specialist RCES

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Pre-Procedural Assessment & Patient Preparation

1.1 Procedure Room Preparation, Equipment Verification & Aseptic Readiness 1.2 Pre-Procedural Clinical Evaluation, Labs, Consents & The Universal Time-Out 1.3 Patient Identification, Transport, HIPAA & Procedural Documentation 1.4 Patient Monitoring Setup, Defibrillator Pads & Pre-Procedural CIED Interrogation 1.5 Vascular Access Planning, Skin Preparation & Sterile Draping

2 Chapter 2: Cardiac Anatomy, Conduction & Electrophysiologic Foundations

2.1 Cardiac Anatomy for the EP Lab: Chambers, Access Routes & Coronary Supply 2.2 The Cardiac Conduction System, Action Potentials & Ion Channel Physiology 2.3 Cardiac Vector Analysis, 12-Lead ECG Fundamentals & Axis Determination

3 Chapter 3: EP Lab Instrumentation, Connectology & Lab Safety

3.1 EP Recording System Architecture, Signal Amplification & Frequency Filters 3.2 Cardiac Stimulator Operation, Junction Box Routing & Noise Troubleshooting 3.3 Electrical Safety, Electrical Units, Electrocautery & Fire Safety 3.4 Radiation Safety Physics, ALARA Principles, Shielding & Dose Limits 3.5 Procedural Supplies, Catheter Inventory, Surgical Instrumentation & Wound Closure

4 Chapter 4: Intra-Procedural Imaging, Sedation & Physiologic Monitoring

4.1 Fluoroscopic Projections (RAO, LAO, AP) & X-ray Tube Optimization 4.2 Intracardiac Echocardiography (ICE) Principles, Views & Catheter Navigation 4.3 Non-Radiographic Imaging: Cardiac CT/MRI, Image Fusion & Ultrasound-Guided Access 4.4 Conscious Sedation Protocols, Airway Management & Hemodynamic Monitoring 4.5 Vital Signs, Normal Laboratory Values & Intra-Procedural Lab Monitoring

5 Chapter 5: EP Pharmacology, Anticoagulation & Emergency Drugs

5.1 Vaughan Williams Antiarrhythmic Classification & EP Electrophysiology 5.2 Diagnostic & Provocative Drugs: Adenosine, Isoproterenol, Epinephrine, Atropine 5.3 Sedation & Analgesia Pharmacology, Reversal Agents & Recovery Scoring 5.4 Heparin Protocol, ACT Monitoring & Emergency Reversal with Protamine 5.5 Oral Anticoagulants, Antiplatelets & Peri-Procedural Management 5.6 ACLS Algorithms & Emergency Medications in the EP Lab

6 Chapter 6: Catheter Navigation, Normal Electrograms & Baseline Intervals

6.1 Standard Diagnostic Catheter Positions & Fluoroscopic/Anatomical Landmarks 6.2 Intracardiac Electrogram Interpretation & Normal Baseline Intervals (PA, AH, HV) 6.3 His Bundle Electrogram Recording, Split His Potentials & Infranodal Conduction

7 Chapter 7: Programmed Electrical Stimulation & Refractory Periods

7.1 Pacing Stimulation Fundamentals, Capture Thresholds & Drive Trains 7.2 Refractory Period Determination (ERP, RRP, FRP) & Sinus Node Function Testing (SNRT, cSNRT) 7.3 AV Nodal Decremental Conduction & Dual AV Nodal Physiology

8 Chapter 8: Diagnostic Evaluation of Supraventricular & Ventricular Tachycardias

8.1 Narrow-Complex Tachycardias: Differential Diagnosis of AVNRT, AVRT & AT 8.2 Diagnostic Pacing Maneuvers: Entrainment, PPI-TCL, V-A-V vs V-A-A-V & His-Refractory PVCs 8.3 Wide-Complex Tachycardias & Ventricular Arrhythmia Mapping Criteria

9 Chapter 9: Bradyarrhythmias, AV Block & Atrial Arrhythmia Recognition

9.1 Bradyarrhythmias, AV Block Classification & Conduction System Disease 9.2 Atrial Fibrillation & Atrial Flutter: Classification, ECG Recognition & Stroke Risk

10 Chapter 10: 3D Electroanatomic Mapping & Ablation Biophysics

10.1 3D Electroanatomic Mapping Systems (Carto, EnSite, Rhythmia) Setup & Troubleshooting 10.2 Activation, Propagation & Bipolar Voltage Substrate Mapping 10.3 Ablation Biophysics: Radiofrequency, Cryoablation & Pulsed Field Ablation (PFA)

11 Chapter 11: Transseptal Access, Catheter Ablation Targets & Endpoints

11.1 Transseptal Puncture: Anatomy, Technique, Imaging Guidance & Complications 11.2 Catheter Ablation of AVNRT Slow Pathway & Accessory Pathways (WPW) 11.3 Cavotricuspid Isthmus (CTI) Ablation for Typical Atrial Flutter 11.4 Pulmonary Vein Isolation (PVI) for AFib & Ventricular Tachycardia Ablation

12 Chapter 12: Cardiac Implantable Electronic Devices: Implantation & Testing

12.1 Pacemaker & Transvenous ICD Implantation Techniques & Safety 12.2 Intra-Procedural Electrical Testing: Sensing, Pacing Thresholds, Impedance & DFT 12.3 Cardiac Resynchronization Therapy (CRT) & Conduction System Pacing (HBP, LBBAP)

13 Chapter 13: CIED Interrogation, Programming & Troubleshooting

13.1 NBG Pacemaker Codes, Pacing Modes & Timing Cycles 13.2 CIED Interrogation Workflow, Programmer Operation & Peri-Procedural Reprogramming 13.3 Interpreting & Conveying Interrogated Data: Diagnostics, Counters & Stored Episodes 13.4 Pacing & Sensing Malfunctions, Electromagnetic Interference & Temporary Pacing

14 Chapter 14: Specialized Devices, Extraction & Acute Procedural Emergencies

14.1 Subcutaneous ICD (S-ICD), Leadless Pacemakers & Left Atrial Appendage Closure 14.2 Transvenous Lead Extraction Tools, Techniques & Safety Precautions 14.3 Acute Procedural Emergencies: Perforation, Tamponade, Pericardiocentesis & Air Embolism

15 Chapter 15: Post-Procedural Care, Hemostasis & Complication Management

15.1 Femoral Hemostasis Techniques: Manual Compression, Figure-of-8 & Closure Devices 15.2 Post-Procedural Complications: Vascular Injury, AV Block, Esophageal Injury & Neurologic Deficits 15.3 Post-Procedural CIED Assessment, Device Follow-Up & Wound Care 15.4 Post-Procedure Patient Recovery, Discharge Education & Clinical Handover

4.5 Vital Signs, Normal Laboratory Values & Intra-Procedural Lab Monitoring

Key Takeaways Explain This Topic AI

Task B5 requires monitoring intra-procedural lab values and names ACT, glucose, and arterial blood gas explicitly.

Normal serum potassium is 3.5-5.0 mEq/L; values below 3.5 promote early afterdepolarizations and torsades, and values above 6.0 widen the QRS and can render tissue inexcitable.

Baseline ACT is 70-180 seconds; left atrial work targets 300-350 seconds, and arterial sheaths are pulled below roughly 150-180 seconds.

Serum magnesium below 1.7 mg/dL frequently coexists with hypokalemia and must be corrected first, because potassium repletion fails while magnesium is low.

End-tidal CO2 rising above 50 mmHg with a falling respiratory rate signals sedation-induced hypoventilation before pulse oximetry desaturates.

Last updated: September 2026

4.5 Vital Signs, Normal Laboratory Values & Intra-Procedural Lab Monitoring

CCI separates "Monitor patient vital signs" (B2) from "Monitor intra-procedural labs values (e.g., ACT, glucose, ABG)" (B5) , and the knowledge list independently names normal vital signs and normal lab values . These are recall items: the exam presents a number and expects instant classification as normal, actionable, or dangerous.

1. Normal Adult Vital Signs

  • Parameter Normal adult range
  • Heart rate 60-100 bpm
  • Respiratory rate 12-20 breaths/min
  • Blood pressure Systolic < 120 and diastolic < 80 mmHg (normal); hypotension generally systolic < 90
  • Mean arterial pressure (MAP) 70-100 mmHg ; ≥ 65 mmHg needed for organ perfusion
  • Temperature 36.5-37.5 °C (97.7-99.5 °F)
  • SpO₂ 95-100% on room air
  • End-tidal CO₂ (EtCO₂) 35-45 mmHg

MAP calculation: MAP = SBP + 2 ( DBP ) 3 or DBP + 1 3 ( Pulse pressure ) \text{MAP} = \frac{\text{SBP} + 2(\text{DBP})}{3} \qquad\text{or}\qquad \text{DBP} + \frac{1}{3}(\text{Pulse pressure}) MAP = 3 SBP + 2 ( DBP ) ​ or DBP + 3 1 ​ ( Pulse pressure )

For a blood pressure of 96/54: MAP = (96 + 108) / 3 = 68 mmHg — at the edge of adequate perfusion and worth announcing.

Pulse pressure (SBP − DBP) narrows in tamponade and hypovolemia and widens in aortic regurgitation. Pulsus paradoxus , an inspiratory systolic fall greater than 10 mmHg, is a cardinal sign of tamponade and is one of the earliest changes a specialist watching an arterial line will see during a perforation.

  • 2. Normal Laboratory Values
  • Electrolytes and renal function
  • Analyte Normal range EP significance
  • Potassium (K⁺) 3.5-5.0 mEq/L The single most arrhythmogenic electrolyte
  • Magnesium (Mg²⁺) 1.7-2.2 mg/dL Cofactor for the Na⁺/K⁺ ATPase; must be corrected before potassium
  • Sodium (Na⁺) 135-145 mEq/L Severe derangement affects conduction
  • Calcium, ionized 4.5-5.6 mg/dL (total 8.5-10.5) Affects QT and contractility
  • BUN 7-20 mg/dL Contrast and drug dosing
  • Creatinine 0.6-1.2 mg/dL Renal clearance of sotalol, dofetilide, DOACs
  • Glucose 70-100 mg/dL fasting Sedation safety; GLP-1 and SGLT2 considerations
  • Hematology and coagulation
  • Analyte Normal range EP significance
  • Hemoglobin 13.5-17.5 g/dL (men), 12.0-15.5 (women) Bleeding risk, oxygen delivery
  • Hematocrit 41-53% (men), 36-46% (women) Serial drop signals occult bleeding
  • Platelets 150,000-400,000/µL Below 50,000 is a relative contraindication to large-bore access
  • INR 0.8-1.1 untreated; 2.0-3.0 on therapeutic warfarin Uninterrupted warfarin ablation strategy
  • aPTT 25-35 s Heparin monitoring outside the lab
  • ACT (baseline) 70-180 s Point-of-care intra-procedural anticoagulation
  • Cardiac and endocrine
  • Analyte Normal / threshold EP significance
  • Troponin Assay-specific; elevated post-ablation is expected Not interpreted as infarction after ablation
  • BNP / NT-proBNP BNP < 100 pg/mL Heart failure status before CRT
  • TSH 0.4-4.0 mIU/L Amiodarone-induced thyroid dysfunction
  • Digoxin level 0.5-2.0 ng/mL (narrower in heart failure) Toxicity causes DAD-mediated arrhythmia
  • 3. Electrolytes as Arrhythmia Mechanisms

Potassium. The exam expects the mechanism, not just the number.

State ECG changes Arrhythmia mechanism

Hypokalemia (< 3.5) ST depression, flattened T, prominent U wave , long QU Prolonged repolarization → early afterdepolarizations → torsades

Hyperkalemia (> 5.5) Peaked T waves → flattened P → widened QRS → sine wave Resting membrane depolarization inactivates sodium channels → conduction slows, tissue becomes inexcitable, capture is lost

Hyperkalemia is the classic cause of an acute rise in pacing threshold with loss of capture in a device patient; hypokalemia is the classic cause of peri-procedural torsades and of failure to maintain sinus rhythm after cardioversion.

Magnesium is a required cofactor for the Na⁺/K⁺ ATPase. While magnesium is low, the pump cannot retain potassium and repletion simply spills into the urine — which is why magnesium is corrected first, or at least concurrently . Intravenous magnesium is also the first-line treatment for torsades de pointes regardless of the serum level.

Calcium shortens the QT when high and lengthens it when low; severe hypocalcemia contributes to a long-QT substrate.

Practical thresholds before elective ablation: correct potassium to at least 4.0 mEq/L and magnesium to at least 2.0 mg/dL, because both improve arrhythmia stability during mapping and reduce the incidence of non-clinical induced arrhythmias.

  • 4. Point-of-Care Testing at the Table
  • Activated clotting time

The ACT is a whole-blood, point-of-care measure of the intrinsic and common pathways, run on a bedside analyzer.

  • Setting Target ACT
  • Baseline, no heparin 70-180 s
  • Right-sided diagnostic EP study Often no heparin, or a low bolus
  • Left atrial work (transseptal, PVI, LA flutter) 300-350 s
  • Retrograde aortic LV mapping ≥ 250-300 s
  • Arterial sheath removal with manual compression < 150-180 s

Sampling technique matters and is testable: draw from an arterial line or a dedicated non-heparinized access , discard an adequate waste volume, and never draw through a heparinized sheath flush line — a contaminated sample returns a falsely prolonged ACT and leads to under-anticoagulation of the patient. The first ACT after the heparin bolus is checked at about 10-15 minutes and then every 20-30 minutes.

Factors that alter ACT independent of heparin dose: hypothermia and hemodilution prolong it; antithrombin III deficiency produces heparin resistance with a stubbornly low ACT despite escalating dosing; high platelet counts and aprotinin can shorten it. Patients on chronic heparin exposure often show relative resistance.

Glucose

Sedation masks hypoglycemia, whose adrenergic and neuroglycopenic signs — diaphoresis, tremor, confusion — are indistinguishable from sedation effects. Point-of-care glucose is checked in any diabetic patient, any patient held NPO longer than expected, and any patient with unexplained agitation or altered mental status. Treatment thresholds: below 70 mg/dL is hypoglycemia; below 54 mg/dL is clinically significant; treat intravenously with dextrose in a sedated patient who cannot swallow.

Two contemporary medication issues appear in current guidance: GLP-1 receptor agonists delay gastric emptying and raise aspiration risk under sedation, and SGLT2 inhibitors are held before procedures because of euglycemic diabetic ketoacidosis risk.

Arterial blood gas

  • Value Normal
  • pH 7.35-7.45
  • PaCO₂ 35-45 mmHg
  • PaO₂ 80-100 mmHg
  • HCO₃⁻ 22-26 mEq/L
  • Base excess −2 to +2
  • SaO₂ 95-100%

The pattern that matters most in the EP lab is acute respiratory acidosis from sedation-induced hypoventilation : pH low, PaCO₂ high, bicarbonate normal because there has been no time for renal compensation. A metabolic acidosis with a rising lactate during a long case suggests hypoperfusion — occult bleeding, tamponade, or prolonged hypotension — and is an early warning that precedes overt hemodynamic collapse.

Capnography provides continuous, breath-by-breath ventilation monitoring and detects hypoventilation and apnea before pulse oximetry falls, particularly in a patient receiving supplemental oxygen whose SpO₂ can remain deceptively normal for minutes after ventilation stops. A rising EtCO₂ with a falling respiratory rate is the earliest actionable signal of over-sedation.